Sign in to view content

Randomized Trial of Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: 5-Year Outcomes

Jeffrey G. Gross, MD, FASRS

Video
Published 2018

Related

Fluorescein Angiography Findings Post-intravitreal Bevacizumab for ROP: Can It Predict the Late-Onset Risk of Recurrence?
Swati Agarwal-Sinha, MD, FASRS
Annual Meeting Talks
2018
Correlation of Peripheral Nonperfusion on Ultra-widefield Fluorescein Angiography with Macular Flow Loss on OCT Angiography in Sickle Cell Retinopathy
Adrienne W. Scott, MD, FASRS
Annual Meeting Talks
2018
LADDER Trial of the Port Delivery System with Ranibizumab: Initial Study Results
Carl C. Awh, MD, FASRS
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more